VIENNA--(BUSINESS WIRE)--Baxter International Inc. (NYSE: BAX), a global leader in acute care therapies, announced today the commercial launch of a new indication for the company’s oXiris set, which ...

All patients undergoing CRRT while on ECLS between 2005 and 2010 at Seattle Children's Hospital (n = 42) were identified by a retrospective review of a prospectively maintained institutional database.

We conducted a single-center observational study of pediatric patients undergoing CRRT during the period of July 2007 through July 2010 at a tertiary care children's hospital. This study was exempt ...

Dublin, Dec. 07, 2021 (GLOBE NEWSWIRE) -- The "U.S. Continuous Renal Replacement Therapy Market Size, Share & Trends Analysis Report by Product (CRRT System, Disposables, Liquids), by Modality (SCUF, ...

Baxter International, a global leader in acute care, announced it has received Emergency Use Authorizations (EUAs) from the US Food and Drug Administration (FDA) for the company’s HF20 Set and ST Set ...

EXETER — Exeter Hospital’s Intensive Care Unit (ICU) was recently able to purchase two Baxter Prismaflex Systems thanks to a generous donation from a family who was looking to support treatment for ...